Author

Mikhail A. Kunst

Observed names: M A Kunst, M. A. Kunst, Michail A. Kunst, Mikhail Kunst, Кунст Михаил Александрович

Institution: Republican Clinical Hospital of the Ministry of Health of the Republic of Tatarstan

Observed institutions: University of Nevada, Reno, Kazan State Medical University, Kazan Federal University, Republican Clinical Hospital of the Ministry of Health of the Republic of Tatarstan, Roche (United Kingdom), Asklepios, University of Coimbra

ORCID: 0000-0002-9721-8262

Observed ORCID: 0000-0002-9721-8262

OpenAlex ID: A5085562168

Differential Immuno-Reactivity to Genomic DNA, RNA and Mitochondrial DNA is Associated with Auto-Immunity

2014 · Vilena V. Ivanova, Svetlana F. Khaiboullina, et al. · Cellular Physiology and Biochemistry · 11

Clinical Outcomes in Patients With COVID-19 and Hematologic Disease

2023 · Olga A. Aleshina, Kristina Zakurdaeva, et al. · Clinical Lymphoma Myeloma & Leukemia · 9

Multiple myeloma: response to treatment and survival of patients according to the interim analysis of the Russian observational, retrospective-prospective, multicenter cohort study (MULTISPECT)

2022 · Vadim V. Ptushkin, Michail A. Kunst, et al. · Terapevticheskii arkhiv · 4

COVID-19 and hematologic diseases: Risk factors and long-term follow-up of CHRONOS19 Registry.

2021 · Kristina Zakurdaeva, Olga A. Gavrilina, et al. · Journal of Clinical Oncology · 4

Outcomes in Patients with Hematologic Disease and COVID-19 in Russia: Interim Analysis of CHRONOS19 Registry

2020 · Olga A. Gavrilina, Kristina Zakurdaeva, et al. · Blood · 4

The use of T-cells with chimeric antigen receptor (CAR-T) in combination with chemotherapy and radiotherapy for the treatment of solid tumors

2024 · M. R. Khaliulin, R. N. Safin, et al. · Advances in molecular oncology · 3

Epidemiological and clinical features of multiple myeloma in Russia: results of a multicenter prospective study

2026 · M. V. Solovev, L. P. Mendeleeva, et al. · MD-Onco · 2

Real-world management of patients with paroxysmal nocturnal hemoglobinuria in Russia: outcomes of the multicenter retrospective RADAR-PNH study

2026 · B. A. Bakirov, G. P. Dimov, et al. · Oncohematology

Analysis of one-year survival and mortality structure of patients with MM according to data from a multicenter Russian prospective study

2026 · M. V. Solovev, L. P. Mendeleeva, et al. · Гематология и трансфузиология

Incidence and Prognostic Value of Bone and Extramedullary Plasmacytomas in Patients with Newly Diagnosed Multiple Myeloma: Data from a Prospective Population-Based Study

2026 · Maksim Valerevich Solovev, L. P. Mendeleeva, et al. · Clinical oncohematology

ABCL-274: Outcomes in Patients with Lymphoproliferative Diseases and COVID-19: Results of a Subgroup Analysis of the CHRONOS19 Registry

2021 · Olga Gavrilina, Kristina Zakurdaeva, et al. · Clinical Lymphoma Myeloma & Leukemia

Poster: ABCL-274: Outcomes in Patients with Lymphoproliferative Diseases and COVID-19: Results of a Subgroup Analysis of the CHRONOS19 Registry

2021 · Olga Gavrilina, Kristina Zakurdaeva, et al. · Clinical Lymphoma Myeloma & Leukemia

To the 50th anniversary of hematology service of the Republic of Tatarstan

2018 · A R Akhmadeev, M A Kunst, et al. · Kazan medical journal

Difficulties in the differential diagnosis of erythema nodosum: Primary myelofibrosis as an etiological factor

2017 · D. I. Abdulganieva, I. F. Fayrushina, et al. · Modern Rheumatology Journal

Works count: 15

Citation count: 37

H-index: 4

I10-index: 1